{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:46:53Z","timestamp":1793306813156,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015866","name":"Gobierno Vasco Departamento de Educaci\u00f3n","doi-asserted-by":"publisher","award":["GIC15\/78 IT-990-16"],"award-info":[{"award-number":["GIC15\/78 IT-990-16"]}],"id":[{"id":"10.13039\/100015866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.biopha.2021.112218","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:36:01Z","timestamp":1632789361000},"page":"112218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["In vitro activities of carvacrol, cinnamaldehyde and thymol against Candida biofilms"],"prefix":"10.1016","volume":"143","author":[{"given":"Katherine","family":"Miranda-Cadena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Marcos-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estibaliz","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Aguirre-Urizar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Quind\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Eraso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112218_bib1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.clindermatol.2016.02.022","article-title":"Oral candidiasis","volume":"34","author":"Millsop","year":"2016","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.biopha.2021.112218_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006056","article-title":"Oropharyngeal candidiasis: fungal invasion and epithelial cell responses","volume":"13","author":"Swidergall","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2021.112218_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0757.2009.00338.x","article-title":"Candida biofilms and oral candidosis: treatment and prevention","volume":"55","author":"Williams","year":"2011","journal-title":"Periodontol 2000"},{"key":"10.1016\/j.biopha.2021.112218_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.archoralbio.2018.07.017","article-title":"Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis","volume":"95","author":"Miranda-Cadena","year":"2018","journal-title":"Arch. Oral. Biol."},{"key":"10.1016\/j.biopha.2021.112218_bib5","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.2174\/138955709789878150","article-title":"Anti-Candida activity of essential oils","volume":"9","author":"Palmeira-de-Oliveira","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.biopha.2021.112218_bib6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.prosdent.2016.05.010","article-title":"Effect of incorporating seed oils on the antifungal property, surface roughness, wettability, weight change, and glucose sorption of a soft liner","volume":"117","author":"Muttagi","year":"2017","journal-title":"J. Prosthet. Dent."},{"key":"10.1016\/j.biopha.2021.112218_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fmicb.2012.00220","article-title":"Antifungal, cytotoxic, and immunomodulatory properties of tea tree oil and its derivative components: potential role in management of oral candidosis in cancer patients","volume":"3","author":"Ramage","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2021.112218_bib8","first-page":"163","article-title":"Characteristics of biofilm formation by Candida albicans","volume":"18","author":"Ramage","year":"2001","journal-title":"Rev. Iberoam. Micol."},{"key":"10.1016\/j.biopha.2021.112218_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mimet.2007.11.010","article-title":"Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates","volume":"72","author":"Peeters","year":"2008","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.biopha.2021.112218_bib10","unstructured":"Arendrup, M.; Meletiadis, J.; Mouton, J.; Lagrou, K.; Hamal, P.; Guinea, J. Subcommittee On Antifungal Susceptibility Testing (AFST), European Committee for Antimicrobial Susceptibility Testing (EUCAST). EUCAST definitive document E.DEF 7.3.2. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts. 2020, Available online: https:\/\/www.eucast.org\/astoffungi\/methodsinantifungalsusceptibilitytesting\/susceptibility_testing_of_yeasts\/. (Accessed 13 July 2021)."},{"key":"10.1016\/j.biopha.2021.112218_bib11","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1111\/j.1469-0691.2012.03880.x","article-title":"EUCAST technical note on the EUCAST definitive document E.Def 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts E.Def 7.2 (EUCAST-AFST)","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.biopha.2021.112218_bib12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.15698\/mic2018.07.638","article-title":"Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms","volume":"5","author":"Van Dijck","year":"2018","journal-title":"Microb. Cell."},{"key":"10.1016\/j.biopha.2021.112218_bib13","unstructured":"EUCAST. (Version 10.0, 2020). Antifungal Agents Breakpoint tables for interpretation of MICs. Available online: http:\/\/www.eucast.org\/clinical_breakpoints\/. (Accessed 13 July 2021)."},{"key":"10.1016\/j.biopha.2021.112218_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0732-8893(02)00525-4","article-title":"Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species","volume":"45","author":"Cant\u00f3n","year":"2003","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.biopha.2021.112218_bib15","first-page":"e172","article-title":"Therapeutic tools for oral candidiasis: Current and new antifungal drugs","volume":"24","author":"Quind\u00f3s","year":"2019","journal-title":"Med. Oral\u00a0Patol. Oral\u00a0Cir. Bucal"},{"key":"10.1016\/j.biopha.2021.112218_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/00016357.2016.1166261","article-title":"Efficacy of citronella and cinnamon essential oils on Candida albicans biofilms","volume":"74","author":"Almeida","year":"2016","journal-title":"Acta Odontol. Scand."},{"key":"10.1016\/j.biopha.2021.112218_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2323\/jgam.60.163","article-title":"Sensitization of Candida albicans biofilms to fluconazole by terpenoids of plant origin","volume":"60","author":"Doke","year":"2014","journal-title":"J. Gen. Appl. Microbiol."},{"key":"10.1016\/j.biopha.2021.112218_bib18","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3389\/fmicb.2017.01641","article-title":"Enhanced killing and antibiofilm activity of encapsulated cinnamaldehyde against Candida albicans","volume":"8","author":"Khan","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2021.112218_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13568-017-0344-y","article-title":"Thymol and carvacrol induce autolysis, stress, growth inhibition and reduce the biofilm formation by Streptococcus mutans","volume":"7","author":"Khan","year":"2017","journal-title":"AMB Express"},{"key":"10.1016\/j.biopha.2021.112218_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.foodchem.2016.04.111","article-title":"Antibacterial and antifungal activities of thymol: a brief review of the literature","volume":"210","author":"Marchese","year":"2016","journal-title":"Food Chem."},{"key":"10.1016\/j.biopha.2021.112218_bib21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.fitote.2016.05.016","article-title":"Cinnamaldehyde and its derivatives, a novel class of antifungal agents","volume":"112","author":"Shreaz","year":"2016","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biopha.2021.112218_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/cod.12591","article-title":"Tea tree oil: contact allergy and chemical composition","volume":"75","author":"De Groot","year":"2016","journal-title":"Contact Dermatitidis"},{"key":"10.1016\/j.biopha.2021.112218_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/2193-1801-2-26","article-title":"Small molecules inhibit growth, viability and ergosterol biosynthesis in Candida albicans","volume":"2","author":"Rajput","year":"2013","journal-title":"Springerplus"},{"key":"10.1016\/j.biopha.2021.112218_bib24","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijantimicag.2008.01.028","article-title":"In vitro activity of terpenes against Candida biofilms","volume":"31","author":"Dalleau","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biopha.2021.112218_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1472-6882-11-119","article-title":"In vitro activities of natural products against oral Candida isolates from denture wearers","volume":"11","author":"Marcos-Arias","year":"2011","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2021.112218_bib26","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1038\/s41598-018-22395-6","article-title":"Essential oils and their components are a class of antifungals with potent vapour-phase-mediated anti-Candida activity","volume":"8","author":"Feyaerts","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.112218_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-micro-091014-104330","article-title":"Candida albicans, biofilms and human disease","volume":"69","author":"Nobile","year":"2015","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2021.112218_bib28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/13693786.2010.507605","article-title":"Assessment of Candida species colonization and denture-related stomatitis in complete denture wearers","volume":"49","author":"Zomorodian","year":"2011","journal-title":"Med. Mycol."},{"key":"10.1016\/j.biopha.2021.112218_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005522","article-title":"Candida glabrata binding to Candida albicans hyphae enables its development in oropharyngeal candidiasis","volume":"12","author":"Tati","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2021.112218_bib30","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/AAC.46.6.1773-1780.2002","article-title":"Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins","volume":"46","author":"Kuhn","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2021.112218_bib31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1130-1406(08)70030-5","article-title":"Activity of anidulafungin against Candida biofilms","volume":"25","author":"Pem\u00e1n","year":"2008","journal-title":"Rev. Iberoam. Micol."},{"key":"10.1016\/j.biopha.2021.112218_bib32","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1093\/jac\/dkw316","article-title":"In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species","volume":"71","author":"Valent\u00edn","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2021.112218_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1099\/jmm.0.000237","article-title":"Comparing apples and oranges: considerations for quantifying candidal biofilms with XTT [2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide] and the need for standardized testing","volume":"65","author":"Ramage","year":"2016","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.biopha.2021.112218_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000828","article-title":"Dispersion as an important step in the Candida albicans biofilm developmental cycle","volume":"6","author":"Uppuluri","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2021.112218_bib35","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijantimicag.2007.12.013","article-title":"Thymol inhibits Candida albicans biofilm formation and mature biofilm","volume":"31","author":"Braga","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biopha.2021.112218_bib36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12906-015-0947-2","article-title":"Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study","volume":"15","author":"de Castro","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2021.112218_bib37","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00784-014-1210-9","article-title":"Influence of daily immersion in denture cleanser on multispecies biofilm","volume":"18","author":"Lucena-Ferreira","year":"2014","journal-title":"Clin. Oral. Investig."},{"key":"10.1016\/j.biopha.2021.112218_bib38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/myc.12453","article-title":"Caries and Candida colonisation in adult patients in Basque Country (Spain)","volume":"59","author":"De-la-Torre","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.biopha.2021.112218_bib39","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/odi.12691","article-title":"Is the oral fungal pathogen Candida albicans a cariogen?","volume":"24","author":"Pereira","year":"2018","journal-title":"Oral. Dis."},{"key":"10.1016\/j.biopha.2021.112218_bib40","article-title":"Development and characterization of monoolein-based liposomes of carvacrol, cinnamaldehyde, citral, or thymol with anti-Candida activities","volume":"65","author":"Miranda-Cadena","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2021.112218_bib41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijantimicag.2013.10.023","article-title":"Strength in numbers: antifungal strategies against fungal biofilms","volume":"43","author":"Ramage","year":"2014","journal-title":"Int. J. Antimicrob. Agents"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221010027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221010027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:39:15Z","timestamp":1771918755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221010027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":41,"alternative-id":["S0753332221010027"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112218","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activities of carvacrol, cinnamaldehyde and thymol against Candida biofilms","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112218"}}